PCLO and metabolic dysfunction-associated steatohepatitis: In humans, hepatic CYP46A1, A4GNT, PCLO, HSF2BP, KCNJ16, and MFSD2A were also found to be elevated in MASH patients compared with healthy controls (Figure 2A, right panel).